Ovid Therapeutics Statistics
Total Valuation
OVID has a market cap or net worth of $226.27 million. The enterprise value is $165.22 million.
| Market Cap | 226.27M |
| Enterprise Value | 165.22M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OVID has 70.71 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Shares Outstanding | 70.71M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 15.99% |
| Owned by Institutions (%) | 64.66% |
| Float | 45.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1.79 |
| PS Ratio | 579.48 |
| Forward PS | 853.58 |
| PB Ratio | 2.59 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 421.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.55, with a Debt / Equity ratio of 0.52.
| Current Ratio | 9.55 |
| Quick Ratio | n/a |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.80% and return on invested capital (ROIC) is -44.31%.
| Return on Equity (ROE) | -49.80% |
| Return on Assets (ROA) | -38.20% |
| Return on Capital (ROIC) | -44.31% |
| Revenue Per Employee | $9,792 |
| Profits Per Employee | -$1.31M |
| Employee Count | 40 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.41% in the last 52 weeks. The beta is 0.69, so OVID's price volatility has been lower than the market average.
| Beta (1Y) | 0.69 |
| 52-Week Price Change | -5.41% |
| 50-Day Moving Average | 3.25 |
| 200-Day Moving Average | 3.43 |
| Relative Strength Index (RSI) | 49.24 |
| Average Volume (30 Days) | 210,396 |
Short Selling Information
The latest short interest is 2.80 million, so 3.96% of the outstanding shares have been sold short.
| Short Interest | 2.80M |
| Short Previous Month | 3.67M |
| Short % of Shares Out | 3.96% |
| Short % of Float | 6.21% |
| Short Ratio (days to cover) | 8.47 |
Income Statement
In the last 12 months, OVID had revenue of $391,695 and -$52.34 million in losses. Loss per share was -$0.74.
| Revenue | 391,695 |
| Gross Profit | 391,695 |
| Operating Income | -59.28M |
| Pretax Income | -52.34M |
| Net Income | -52.34M |
| EBITDA | -50.74M |
| EBIT | -52.34M |
| Loss Per Share | -$0.74 |
Balance Sheet
The company has $107.76 million in cash and $46.00 million in debt, giving a net cash position of $61.76 million or $0.87 per share.
| Cash & Cash Equivalents | 107.76M |
| Total Debt | 46.00M |
| Net Cash | 61.76M |
| Net Cash Per Share | $0.87 |
| Equity / Book Value | 87.80M |
| Book Value Per Share | 1.24 |
| Working Capital | 98.12M |
Cash Flow
In the last 12 months, operating cash flow was -$45.78 million and capital expenditures -$40,308, giving a free cash flow of -$45.82 million.
| Operating Cash Flow | -45.78M |
| Capital Expenditures | -40,308 |
| Free Cash Flow | -45.82M |
| FCF Per Share | -$0.65 |
Margins
Gross margin is 100.00%, with operating and profit margins of -15,134.60% and -13,362.17%.
| Gross Margin | 100.00% |
| Operating Margin | -15,134.60% |
| Pretax Margin | -13,362.17% |
| Profit Margin | -13,362.17% |
| EBITDA Margin | -12,954.57% |
| EBIT Margin | -13,362.17% |
| FCF Margin | -11,698.19% |
Dividends & Yields
OVID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.22% |
| Shareholder Yield | -0.22% |
| Earnings Yield | -23.06% |
| FCF Yield | -20.19% |
Analyst Forecast
The average price target for OVID is $8.00, which is 150.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 150.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 224.36% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OVID has an Altman Z-Score of -0.66 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.66 |
| Piotroski F-Score | 1 |